HUINNO focuseson changing the way clinicians and patients manage chronic cardiac diseases using their proprietary breakthrough technologies in wearable devices and AI-based analytics cloud. HUINNO’s clinically-tested platform is capable of continuously measuring a variety of vital health data in real-time with clinical-grade accuracy. By combining wrist and chest wearables with artificial intelligence, HUINNO provides superior real-time cardiac biometrics including ECG, Blood Pressure, Heart Rate, SpO2. Delivering healthcare providers with an effective remote patient monitoring solution that drastically improves chronic cardiac disease prevention while lowering readmission rate compared to the existing standard of care. HUINNO’s app and cloud-based eco-system also allow consumers to access longitudinal trend analysis of blood pressure, medication compliance, and nutritional / exercise habits as well as coaching and medication titration from HUINNO’s clinical experts. Founded by Steven Baek and YJ Gil in 2014, HUINNO is backed by investors that include Yuhan Corporation and is headquartered in Boston.